BenevolentAI Results Presentation Deck

The Benevolent Platform™ empowers scientists with industry-leading drug discovery Al Comprehensive data foundations DISEASE EXPLORATION Can we treat ALS by reversing Autophagy impairment in microglia by reducing oxidative stress" 000 Target Endpoint What we will measure Cell type Mechanism sign TARGET PREDICTIONS W B H TARGET IDENTIFICATION LARGE LANGUAGE MODEL GRAPH MODELS GENETIC & GENOMIC MODELS DATA QUERIES TRANSCRIPTOMICS Biology first MODELS TARGET ASSESSMENT Ⓒ O X Small Molecule XNOVELTY PATENT LANDSCAPE ( Alternative Modalities Hypothesis driven TRACTABILITY (?) SELECTIVITY BenevolentAl Proprietary TARGET VALIDATION Portfolio Entry ● ● Proprietary Al models reason across multi-modal data to discover novel targets Enables scientists to assess & select only the most promising targets to take into wet lab experiments Efficiently surfaces scientific evidence to support higher confidence decisions Data fed back into the Knowledge Graph to enhance future predictions Benevolent 7

View entire presentation